Taken together, these in vitro and in vivo results confirmed that PA inhibited development of diabetic renal fibrosis at least partially via activating the Nrf2/ARE pathway in the HG microenvironment, leading to reductions in expressions of FN and ICAM-1 in GMCs and thus inhibiting DN. The gene discussed is ICAM1; the disease is liver dysplastic nodule.